Advertisement

Advertisement

2022 Community Oncology Alliance Annual Meeting

Multiple Myeloma

By Caroline Helwick  / June 10, 2022  / 2022 Community Oncology Alliance Annual Meeting

Multiple Myeloma: Treatment Conundrums

The availability of numerous new agents for treating multiple myeloma has created some “conundrums” for clinicians, said Sergio Giralt, MD, Deputy Head of the Division of Hematologic Malignancies at M...

Issues in Oncology

By Chase Doyle  / May 25, 2022  / 2022 Community Oncology Alliance Annual Meeting

The Future of Community Oncology Practice

Although community oncology practice may have been changing before the COVID-19 pandemic, it amplified industry trends. At the 2022 Community Oncology Alliance’s Community Oncology Conference, a panel...

Advertisement

Advertisement




Apr
19
Today In Oncology
Alectinib Approved as Adjuvant Treatment for ALK-Positive Non–Small Cell Lung Cancer
Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC
Accelerated Aging May Be a Risk Factor for Early-Onset Cancers in Younger Generations
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
Novel SPECT/CT Imaging Technique Under Study in Prostate Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside